Logo

American Heart Association

  144
  0


Final ID:

Limitations of prior coronary revascularization trials

  • Gaudino, Mario  ( Weill Cornell Medicine , New York , New York , United States )
  • Stone, Gregg  ( Mount Sinai Medical Center , New York City , New York , United States )
  • Author Disclosures:
    Mario Gaudino: DO have relevant financial relationships ; Advisor:Abbott Vascular:Past (completed) | Gregg Stone: DO have relevant financial relationships ; Speaker:Medtronic:Past (completed) ; Consultant:HeartFlow:Active (exists now) ; Consultant:Therox:Active (exists now) ; Consultant:Valfix:Active (exists now) ; Consultant:Elucid:Past (completed) ; Consultant:Apollo Therapeutics:Past (completed) ; Consultant:Vectorious:Past (completed) ; Consultant:Miracor:Past (completed) ; Consultant:Robocath:Past (completed) ; Consultant:Ablative Solutions:Past (completed) ; Consultant:Daiichi Sankyo:Past (completed) ; Consultant:Abbott:Past (completed) ; Speaker:Boehringer Ingelheim:Past (completed) ; Speaker:Amgen:Past (completed) ; Speaker:Abiomed:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:
More abstracts on this topic:
Predictors and 3-Year Outcomes of Compromised Left Circumflex Coronary Artery After Left Main Crossover Stenting

Ullah Hameed, Guo Ning, Yuan Zuyi, Hamed Karim, Ullah Najeeb, Asad Khan Muhammad, Ullah Habib

Ostial versus Crossover Stenting for Ostial Left Anterior Descending Artery Lesions: A Systematic Review and Meta-Analysis

Desai Parth, Suffredini John, Koh Stephanie, Bk Anupama, Khalid Umair, Kayani Waleed, Jia Xiaoming

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available